Ditchcarbon
  • Contact
  1. Organizations
  2. Ipsen
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 14 days ago

Ipsen

Company website

Ipsen S.A., a global biopharmaceutical group headquartered in France, has established itself as a leader in the healthcare industry since its founding in 1929. With a strong presence in Europe, North America, and Asia, Ipsen focuses on innovative treatments in oncology, neuroscience, and rare diseases. The company is renowned for its core products, including Somatuline® and Cabometyx®, which are distinguished by their unique mechanisms of action and efficacy in treating complex conditions. Ipsen's commitment to research and development has led to significant milestones, including the expansion of its product portfolio and strategic partnerships that enhance its market position. Recognised for its dedication to patient care and innovation, Ipsen continues to make strides in the biopharmaceutical sector, contributing to advancements that improve the quality of life for patients worldwide.

DitchCarbon Score

How does Ipsen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

82

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Ipsen's score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

89%

Let us know if this data was useful to you

Ipsen's reported carbon emissions

In 2024, Ipsen reported total greenhouse gas emissions of approximately 99,320,000 kg CO2e globally, comprising 9,932,000 kg CO2e from Scope 1, 289,000 kg CO2e from Scope 2, and 90,705,000 kg CO2e from Scope 3 emissions. Notably, in France, Ipsen's Scope 1 emissions reached about 2,659,700 kg CO2e, while Scope 2 emissions were not disclosed. Ipsen has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 emissions by 50% by 2030 from a 2019 baseline. Additionally, the company targets a 20% reduction in Scope 3 emissions within the same timeframe. For long-term goals, Ipsen is committed to achieving net-zero greenhouse gas emissions across all scopes by 2045, with a target to reduce absolute emissions by at least 90% from the 2019 baseline. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to the Paris Agreement's goal of limiting global warming to 1.5°C. The company is currently on track to meet its near-term targets, demonstrating a strong commitment to sustainability and climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192021202220232024
Scope 1
14,316,000
00,000,000
00,000,000
00,000,000
0,000,000
Scope 2
4,343,000
0,000,000
0,000,000
000,000
000,000
Scope 3
121,718,000
00,000,000
00,000,000
-
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ipsen's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ipsen is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ipsen is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

RECORDATI

LU
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Chiesi Farmaceutici

IT
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Bayer

DE
•
Chemicals nec
Updated 3 days ago

Sandoz

CH
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy